|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The Journal of Immunology, Vol 155, Issue 4 2077-2084, Copyright © 1995 by American Association of Immunologists
ARTICLES |
V Boutard, R Havouis, B Fouqueray, C Philippe, JP Moulinoux and L Baud
INSERM Unit 64, Tenon Hospital, Paris, France.
Macrophage arginine metabolism via nitric oxide (NO) synthase and arginase pathways reduces and enhances tumor cell proliferation, respectively. Transforming growth factor-beta (TGF-beta) has been shown to down-regulate the NO synthase pathway. The present study describes the effect of TGF-beta on the arginase pathway. TGF-beta up-regulated arginase activity in rat peritoneal macrophages as assessed by measuring the generation of [14C]urea from [14C]-L-arginine in the presence of NG-monomethyl-L-arginine (L-NMMA). The stimulation, which reached fivefold after a 48-h exposure of macrophages to 10 ng/ml TGF- beta, was due to reduction in Km value of arginase. TGF-beta-induced up- regulation of arginase activity led to the release of more polyamines, mainly putrescine. The role of this up-regulation on macrophage cytotoxicity toward L-929 tumor cells was analyzed in coculture experiments. Macrophages blunted DNA synthesis by L-929 cells as assessed by measuring the incorporation of [3H]TdR into the cells and the proportion of cells in the G2 phase. Addition of TGF-beta in the presence of L-NMMA permitted L-929 cells cocultured with macrophages to resume DNA synthesis. The mechanism responsible for this restoration was the up-regulation of arginase activity rather than the down- regulation of NO synthase activity since TGF-beta in the presence of L- NMMA failed to further reduce NO synthase activity whereas it still enhanced arginase activity; synthetic putrescine (1-10 microM) also blunted macrophage cytotoxicity toward L-929 cells. This is the first evidence that TGF-beta up-regulates arginase activity in macrophages and, hence, limits macrophage-dependent cytostasis.
This article has been cited by other articles:
![]() |
S. Kim, G. Buchlis, Z. G. Fridlender, J. Sun, V. Kapoor, G. Cheng, A. Haas, H. K. Cheung, X. Zhang, M. Corbley, et al. Systemic Blockade of Transforming Growth Factor-{beta} Signaling Augments the Efficacy of Immunogene Therapy Cancer Res., December 15, 2008; 68(24): 10247 - 10256. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Vidal, A. L. Serrano, M. Tjwa, M. Suelves, E. Ardite, R. De Mori, B. Baeza-Raja, M. Martinez de Lagran, P. Lafuste, V. Ruiz-Bonilla, et al. Fibrinogen drives dystrophic muscle fibrosis via a TGF{beta}/alternative macrophage activation pathway Genes & Dev., July 1, 2008; 22(13): 1747 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Letavernier, J. Perez, A. Bellocq, L. Mesnard, A. de Castro Keller, J.-P. Haymann, and L. Baud Targeting the Calpain/Calpastatin System as a New Strategy to Prevent Cardiovascular Remodeling in Angiotensin II-Induced Hypertension Circ. Res., March 28, 2008; 102(6): 720 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Gaur, S. C. Roberts, R. P. Dalvi, I. Corraliza, B. Ullman, and M. E. Wilson An Effect of Parasite-Encoded Arginase on the Outcome of Murine Cutaneous Leishmaniasis J. Immunol., December 15, 2007; 179(12): 8446 - 8453. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Talmadge Pathways Mediating the Expansion and Immunosuppressive Activity of Myeloid-Derived Suppressor Cells and Their Relevance to Cancer Therapy Clin. Cancer Res., September 15, 2007; 13(18): 5243 - 5248. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Johann, V. Barra, A.-M. Kuhn, A. Weigert, A. von Knethen, and B. Brune Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production FASEB J, September 1, 2007; 21(11): 2704 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wanasen, C. L. MacLeod, L. G. Ellies, and L. Soong L-Arginine and Cationic Amino Acid Transporter 2B Regulate Growth and Survival of Leishmania amazonensis Amastigotes in Macrophages Infect. Immun., June 1, 2007; 75(6): 2802 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Erdely, D. Kepka-Lenhart, M. Clark, P. Zeidler-Erdely, M. Poljakovic, W. J. Calhoun, and S. M. Morris Jr Inhibition of phosphodiesterase 4 amplifies cytokine-dependent induction of arginase in macrophages Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L534 - L539. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Di Costanzo, G. Sabio, A. Mora, P. C. Rodriguez, A. C. Ochoa, F. Centeno, and D. W. Christianson Crystal structure of human arginase I at 1.29-A resolution and exploration of inhibition in the immune response PNAS, September 13, 2005; 102(37): 13058 - 13063. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Iniesta, J. Carcelen, I. Molano, P. M. V. Peixoto, E. Redondo, P. Parra, M. Mangas, I. Monroy, M. L. Campo, C. G. Nieto, et al. Arginase I Induction during Leishmania major Infection Mediates the Development of Disease Infect. Immun., September 1, 2005; 73(9): 6085 - 6090. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Stechmiller, B. Childress, and L. Cowan Arginine Supplementation and Wound Healing Nutr Clin Pract, February 1, 2005; 20(1): 52 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Spaner Amplifying cancer vaccine responses by modifying pathogenic gene programs in tumor cells J. Leukoc. Biol., August 1, 2004; 76(2): 338 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Duleu, P. Vincendeau, P. Courtois, S. Semballa, I. Lagroye, S. Daulouede, J.-L. Boucher, K. T. Wilson, B. Veyret, and A. P. Gobert Mouse Strain Susceptibility to Trypanosome Infection: An Arginase-Dependent Effect J. Immunol., May 15, 2004; 172(10): 6298 - 6303. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Rodriguez, H. K. Chang, and M. E. Wilson Novel Program of Macrophage Gene Expression Induced by Phagocytosis of Leishmania chagasi Infect. Immun., April 1, 2004; 72(4): 2111 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Katakura, M. Miyazaki, M. Kobayashi, D. N. Herndon, and F. Suzuki CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages J. Immunol., February 1, 2004; 172(3): 1407 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kusmartsev, Y. Nefedova, D. Yoder, and D. I. Gabrilovich Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species J. Immunol., January 15, 2004; 172(2): 989 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. El-Gayar, H. Thuring-Nahler, J. Pfeilschifter, M. Rollinghoff, and C. Bogdan Translational Control of Inducible Nitric Oxide Synthase by IL-13 and Arginine Availability in Inflammatory Macrophages J. Immunol., November 1, 2003; 171(9): 4561 - 4568. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Endo, S. Oyadomari, Y. Terasaki, M. Takeya, M. Suga, M. Mori, and T. Gotoh Induction of arginase I and II in bleomycin-induced fibrosis of mouse lung Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L313 - L321. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, J. A. Van Ginderachter, L. Brys, P. De Baetselier, G. Raes, and A. B. Geldhof Nitric Oxide-Independent CTL Suppression during Tumor Progression: Association with Arginase-Producing (M2) Myeloid Cells J. Immunol., May 15, 2003; 170(10): 5064 - 5074. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Gantt, S. Schultz-Cherry, N. Rodriguez, S. M. B. Jeronimo, E. T. Nascimento, T. L. Goldman, T. J. Recker, M. A. Miller, and M. E. Wilson Activation of TGF-{beta} by Leishmania chagasi: Importance for Parasite Survival in Macrophages J. Immunol., March 1, 2003; 170(5): 2613 - 2620. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stempin, L. Giordanengo, S. Gea, and F. Cerban Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen J. Leukoc. Biol., October 1, 2002; 72(4): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Gregory and E. J. Wing Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections J. Leukoc. Biol., August 1, 2002; 72(2): 239 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. B. Bastos, J. M. Alvarez, C. R. F. Marinho, L. V. Rizzo, and M. R. D'Imperio Lima Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile J. Leukoc. Biol., February 1, 2002; 71(2): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Durante, L. Liao, S. V. Reyna, K. J. Peyton, and A. I. Schafer Transforming Growth Factor-{beta}1 Stimulates L-Arginine Transport and Metabolism in Vascular Smooth Muscle Cells : Role in Polyamine and Collagen Synthesis Circulation, February 27, 2001; 103(8): 1121 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-I Chang, J. C. Liao, and L. Kuo Macrophage Arginase Promotes Tumor Cell Growth and Suppresses Nitric Oxide-mediated Tumor Cytotoxicity Cancer Res., February 1, 2001; 61(3): 1100 - 1106. [Abstract] [Full Text] |
||||
![]() |
C.-I Chang, B. Zoghi, J. C. Liao, and L. Kuo The Involvement of Tyrosine Kinases, Cyclic AMP/Protein Kinase A, and p38 Mitogen-Activated Protein Kinase in IL-13-Mediated Arginase I Induction in Macrophages: Its Implications in IL-13-Inhibited Nitric Oxide Production J. Immunol., August 15, 2000; 165(4): 2134 - 2141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Gobert, S. Daulouede, M. Lepoivre, J. L. Boucher, B. Bouteille, A. Buguet, R. Cespuglio, B. Veyret, and P. Vincendeau L-Arginine Availability Modulates Local Nitric Oxide Production and Parasite Killing in Experimental Trypanosomiasis Infect. Immun., August 1, 2000; 68(8): 4653 - 4657. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill M-1/M-2 Macrophages and the Th1/Th2 Paradigm J. Immunol., June 15, 2000; 164(12): 6166 - 6173. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tsutsui and T. Kamiyama Transforming Growth Factor beta -Induced Failure of Resistance to Infection with Blood-Stage Plasmodium chabaudi in Mice Infect. Immun., May 1, 1999; 67(5): 2306 - 2311. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Louis, V. Mody, W. L. Henry Jr., J. S. Reichner, and J. E. Albina Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R237 - R242. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Que, S. P. Kantrow, C. P. Jenkinson, C. A. Piantadosi, and Y.-C. T. Huang Induction of arginase isoforms in the lung during hyperoxia Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L96 - L102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Munder, K. Eichmann, and M. Modolell Alternative Metabolic States in Murine Macrophages Reflected by the Nitric Oxide Synthase/Arginase Balance: Competitive Regulation by CD4+ T Cells Correlates with Th1/Th2 Phenotype J. Immunol., June 1, 1998; 160(11): 5347 - 5354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Waddington, F. W. K. Tam, H. T. Cook, and V. Cattell Arginase activity is modulated by IL-4 and HOArg in nephritic glomeruli and mesangial cells Am J Physiol Renal Physiol, March 1, 1998; 274(3): F473 - F480. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bellocq, S. Suberville, C. Philippe, F. Bertrand, J. Perez, B. Fouqueray, G. Cherqui, and L. Baud Low Environmental pH Is Responsible for the Induction of Nitric-oxide Synthase in Macrophages. EVIDENCE FOR INVOLVEMENT OF NUCLEAR FACTOR-kappa B ACTIVATION J. Biol. Chem., February 27, 1998; 273(9): 5086 - 5092. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-I Chang, J. C. Liao, and L. Kuo Arginase modulates nitric oxide production in activated macrophages Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H342 - H348. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |